Human medicines European public assessment report (EPAR): Docetaxel Teva, docetaxel, Head and Neck Neoplasms,Carcinoma, Non-Small-Cell Lung,Adenocarcinoma,Prostatic Neoplasms,Stomach Neoplasms,Breast Neoplasms, Date of authorisation: 26/01/2010, Revision: 17, Status: Authorised

2019 ◽  
Author(s):  
Keyword(s):  
Breast Neoplasms ◽  
Lung Adenocarcinoma ◽  
Head And Neck ◽  
Prostatic Neoplasms ◽  
Head And Neck Neoplasms ◽  
Small Cell ◽  
Small Cell Lung ◽  
Assessment Report ◽  
European Public ◽  
European Public Assessment Report
Sign in / Sign up

Export Citation Format

Share Document